In focus · trending topic

anthrax vaccine

2 stories · following the connections

Emergent BioSolutions Announces Successful Completion of Mutual Recognition Procedure for Market Authorization of BioThrax in European Countries

By Nasdaq OMXApr 12, 2018, 10:30 AM UTC

Emergent BioSolutions Awarded BARDA Contract for Advanced Development and Delivery of NuThrax, a Next Generation Anthrax Vaccine, Valued at Up to $1.6 Billion

By Nasdaq OMXSep 30, 2016, 1:04 PM UTC